Cargando…

Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series

PURPOSE: To report our findings in three cases of an inflamed conjunctival nevus whose size and degree of pigmentation were reduced by topical antiallergic and immunosuppressive ophthalmic solutions. METHODS: Observational case series. Three patients with inflamed conjunctival nevus were examined by...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Kumiko, Takeuchi, Maki, Yonekawa, Yuka, Kashima, Yuzen, Hirano, Koji, Kondo, Mineo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886228/
https://www.ncbi.nlm.nih.gov/pubmed/33603334
http://dx.doi.org/10.2147/OPTH.S299288
_version_ 1783651755649662976
author Kato, Kumiko
Takeuchi, Maki
Yonekawa, Yuka
Kashima, Yuzen
Hirano, Koji
Kondo, Mineo
author_facet Kato, Kumiko
Takeuchi, Maki
Yonekawa, Yuka
Kashima, Yuzen
Hirano, Koji
Kondo, Mineo
author_sort Kato, Kumiko
collection PubMed
description PURPOSE: To report our findings in three cases of an inflamed conjunctival nevus whose size and degree of pigmentation were reduced by topical antiallergic and immunosuppressive ophthalmic solutions. METHODS: Observational case series. Three patients with inflamed conjunctival nevus were examined by slit-lamp biomicroscopy, and the findings before and after the treatments were compared. RESULTS: All three patients had a slightly pigmented and edematous conjunctival tumor at the corneal limbal area. The tumors were hyperemic, and papillae and follicles were present on the superior conjunctiva in all patients. All of the patients had an allergic predisposition. The antiallergic treatment not only resolved the hyperemia and edema of the palpebral conjunctiva, but also reduced the tumor size. In one case, the topical antiallergic agent alone led to a reduction of the tumor size. A combination of topical antiallergic agent and topical immunosuppressant was effective in reducing the tumor size and degree of pigmentation in the other two patients. CONCLUSION: The hyperemia and pigmentation in eyes with inflamed conjunctival nevus can be resolved by topical antiallergic agent and topical immunosuppressant without resection of the tumor.
format Online
Article
Text
id pubmed-7886228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78862282021-02-17 Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series Kato, Kumiko Takeuchi, Maki Yonekawa, Yuka Kashima, Yuzen Hirano, Koji Kondo, Mineo Clin Ophthalmol Case Series PURPOSE: To report our findings in three cases of an inflamed conjunctival nevus whose size and degree of pigmentation were reduced by topical antiallergic and immunosuppressive ophthalmic solutions. METHODS: Observational case series. Three patients with inflamed conjunctival nevus were examined by slit-lamp biomicroscopy, and the findings before and after the treatments were compared. RESULTS: All three patients had a slightly pigmented and edematous conjunctival tumor at the corneal limbal area. The tumors were hyperemic, and papillae and follicles were present on the superior conjunctiva in all patients. All of the patients had an allergic predisposition. The antiallergic treatment not only resolved the hyperemia and edema of the palpebral conjunctiva, but also reduced the tumor size. In one case, the topical antiallergic agent alone led to a reduction of the tumor size. A combination of topical antiallergic agent and topical immunosuppressant was effective in reducing the tumor size and degree of pigmentation in the other two patients. CONCLUSION: The hyperemia and pigmentation in eyes with inflamed conjunctival nevus can be resolved by topical antiallergic agent and topical immunosuppressant without resection of the tumor. Dove 2021-02-12 /pmc/articles/PMC7886228/ /pubmed/33603334 http://dx.doi.org/10.2147/OPTH.S299288 Text en © 2021 Kato et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Series
Kato, Kumiko
Takeuchi, Maki
Yonekawa, Yuka
Kashima, Yuzen
Hirano, Koji
Kondo, Mineo
Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
title Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
title_full Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
title_fullStr Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
title_full_unstemmed Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
title_short Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
title_sort management of inflamed conjunctival nevus with topical antiallergic medications: case series
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886228/
https://www.ncbi.nlm.nih.gov/pubmed/33603334
http://dx.doi.org/10.2147/OPTH.S299288
work_keys_str_mv AT katokumiko managementofinflamedconjunctivalnevuswithtopicalantiallergicmedicationscaseseries
AT takeuchimaki managementofinflamedconjunctivalnevuswithtopicalantiallergicmedicationscaseseries
AT yonekawayuka managementofinflamedconjunctivalnevuswithtopicalantiallergicmedicationscaseseries
AT kashimayuzen managementofinflamedconjunctivalnevuswithtopicalantiallergicmedicationscaseseries
AT hiranokoji managementofinflamedconjunctivalnevuswithtopicalantiallergicmedicationscaseseries
AT kondomineo managementofinflamedconjunctivalnevuswithtopicalantiallergicmedicationscaseseries